Prof. Janet Mifsud

Prof. Janet Mifsud

Prof. Janet Mifsud



Faculty of Medicine & Surgery
Clinical Pharmacology & Therapeutics
University of Malta
  +356 2340 2845
Prof Janet Mifsud obtained her PhD in UK in 1995 on the pharmacology of chiral antiepileptic drugs. Her research activities in epilepsy are undertaken with colleagues in Mater Dei Hospital, University College London and numerous other international epilepsy centres. She has published extensively and has been appointed on the organising and scientific committees of several international epilepsy conferences. Prof Mifsud was Secretary General for the European Epilepsy Academy and also Vice-President for the International Bureau for Epilepsy; and she is presently member, Joint Task Force, European Epilepsy Research and Advocacy. She is an advisor, Caritas Malta Epilepsy Association. She was officially awarded the title of Epilepsy Ambassador by the International League Against epilepsy and International Bureau of Epilepsy in 2019.

Prof Mifsud co-ordinates pharmacology study units offered at the University of Malta for Faculties of Medicine and Surgery; Health Sciences; Science; Education; and Dental Surgery. She also co-ordinates a Masters in Pharmacotoxicology and the preparation of final year MD students for the UK Prescribing Skills Assessment. She was elected Fellow of the British Pharmacological Society in 2017 and in 2019 was appointed Review Science Editor for the British Journal of Clinical Pharmacology.

She is involved in several EU and internationally funded projects in FP7. H2020, Ersamus+ and IMI. She has also been invited to act as external expert evaluator for scientific projects for several international and European wide panels. Prof Mifsud is national expert on the Pharmacokinetics Working Group (PKWP) in European Medicines Agency.

On a national level, she was the first Commissioner, National Commission for the Promotion of Equality (NCPE) and was for several years a member of the Public Service Commission, a member of the Centre for Freedom from Addiction, President's Foundation for the Wellbeing of Society; and a member of the Fund for Voluntary Organisations, Malta Community Chest Fund. She is presently Board Member, New Hope Services for Drug Rehabilitation, Caritas Malta.
  • Pharmacokinetics, Pharmacometrics and Pharmacogenetics
  • Pharmacology of drugs used in chronic neurological disorders specifically anti-epileptic drugs
  • Pharmacotoxicology
  • Abuse and misuse of over the counter drugs and Drug Doping in sports
  • Stigma and inclusion in epilepsy
  • Ethical issues in health care and pharmacology
  • Gender and science
  • CHE1012 - Principles of Chemistry and Biochemistry related to Care
  • CPH1710 - Pharmacological Principles in Dentistry
  • CPH1800 - Basic Principles of General Pharmacology in Food Science
  • CPH1902 - Overview of Drug Classes and Function
  • CPH1905 - Pharmacokinetics and Pharmacodynamics 1
  • CPH1909 - Pharmacology Seminars 1
  • CPH2011 - Drugs used in Disorders of the Nervous and Cardiovascular Systems
  • CPH2110 - Introduction to Molecular and Clinical Pharmacology
  • CPH2301 - Introduction to Pharmacology for Applied Biomedical Science Students
  • CPH2402 - Pharmacology for Allied Health Care Professionals
  • CPH2404 - Pharmacology for Midwifery Students
  • CPH2901 - Approaches to Analysis of Drugs and Metabolites
  • CPH2902 - Pharmacokinetics and Pharmacodynamics 2
  • CPH2903 - Antibiotics, Antifungals, Antivirals and Antihelminthics
  • CPH2907 - Societal impact of Pharmacology and Rational Drug Use
  • CPH2910 - Pharmacology Seminars 2
  • CPH3010 - Drugs used in Asthma, COPD and Epilepsy: Applications of Pharmacokinetics
  • CPH3601 - Introduction to Pharmacology for Chemistry Students
  • CPH3700 - Theory and Applications of Molecular Pharmacology
  • CPH4120 - Applied Molecular and Clinical Pharmacology
  • CPH4500 - Introduction to Pharmacology for Biology and Chemistry Students
  • CPH4600 - Pharmacology for Podiatry Students
  • CPH5404 - Clinical Toxicology and Management of Poisoning of Commonly Used Pharmaceuticals 2
  • CPH5405 - Diagnosis and Management of Toxicological Emergencies
  • CPH5406 - Risk Assessment and Management in the Clinical Pharmacotoxicology Setting
  • CPH5407 - Poisoning, Toxicology and Treatment of Non-pharmacological Agents
  • CPH5408 - Clinical Management of Poisoning with Drugs of Abuse and in Sports
  • CPH5409 - Preventive, Forensic and Regulatory Pharmacotoxicology
  • GRS5012 - Introduction to Gender, Sexuality and Feminism
  • MDS1013 - Organisation of the Body
  • MDS1014 - Renal System
  • MDS2009 - Pharmacology
  • MDS2031 - Gastrointestinal System
  • MDS3011 - Clinical Pharmacology and Therapeutics 1
  • MDS4013 - Neurology and Ophthalmology
  • PSY3644 - Child and Adolescent Psychopathology
  • PSY5618 - Psychotherapeutic Approaches: CBT, Ethics and Psychopharmacology
  • RAD3330 - Pharmacology and Radiopharmacy for Radiographers
Research work in progress

- Pharmacokinetics and pharmacogenetics of drugs used in chronic neurological disorders
- OTC drug use and misuse and drug doping in sports
- Neurotoxicology and poisoning
- Stigma and educational inclusion in epilepsy

Involvement in projects and ongoing collaborations

- Member of the Scientific Advisory Board, IMI project NeuroDeRixk Neurotoxicity DeRisking in
Preclinical Drug Discovery IMI-JU 821528 2019-2023
- Consortium Parter, H2020 GENDER ACTION GENDer equality in the ERA Community To Innovate
policy implementatiON. Coordination and Support Action SwafS-19-216 2017-2021
- Chair, Dissemination board and Ethics Board FP7 DESIRE Development and Epilepsy Strategies
for innovative research to improve Diagnosis, Prevention and Treatment in children with
Difficult to Treat Epilepsy (Health-F2-602531-2013)(2013-2018)
- Workpackage leader Parter, Erasmus+, IT-based international diploma and professional
certificates in clinical toxicology (ITCT)(KA2 561915-EPP-1-2015-1-EG-EPPKA2-CBHE-JP)(2015-
- Workpackage leader Partner, LLP Erasmus Network, Science for Prevention Academic Network
(SPAN) (2013-2015)
- Partner, Leonardo Da Vinci LLP EU project on disability education (2009-2012)
- Chair, Dissemination board EU funded FP6 project EPICURE: Functional Genomics and
Neurobiology of Epilepsy: A Basis for New Therapeutic Strategies (LSH-037315). (2004-2009)
- UNESCO grant on learning impairment in epilepsy;
- Co-coordinator Grundtvig project. Curricular Education for Professionals Allied to Medicine
(PAMs) in Epilepsy 2006-2011.
- Co-ordinator of a UNESCO funded project on Gender Gap in science and technology in Malta,
- Co-ordinator of an EU Youth Grant - Epilepsy Youth in Europe, 2003

- Epilepsy Ambassador, International League Against Epilepsy and International Bureau of
Epilepsy, 2019
- Elected Fellow of the British Pharmacological Society, 2017
- Pektur award, Commission for Persons with Disability, 2017
- Italo Maltese award to La Sapienza University Rome Italy, 2009
- Visiting fellow US Fulbright scholarship to the University of Minnesota, 2007
- Pektur award, Commission for Persons with Disability, 2001
- DAAD grant, Bethel Epilepsy Clinic, Germany, 1999